<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="6584" end="6590" sStart="6492" offset="92" sid="r8.number.n.0348" wn="8" wnkey="number%1:10:02::" text="The first two exons of the GPC5 gene are present in BAC clone accession number AL138714, exons 3,4,5 in AC027429, exon 6 in AL162456, exon 7 in AL163537 and exon 8 in AL157363 (Table 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="17770" end="17776" sStart="null" offset="56" sid="null" wn="1" wnkey="normal%3:00:01::" text="Of the 23 subjects studied, 5 (3 affected and 2 normal) were heterozygous Ala/Val." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="7338" end="7344" sStart="null" offset="52" sid="null" wn="1" wnkey="normal%3:00:01::" text="Of these, 6 individuals (3 affected and 3 normal) were homozygous CC (exon 17), 15 (11 affected and 4 normal) were heterozygous TC (exon 17) and three were heterozygous AG (exon 23)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="17770" end="17776" sStart="null" offset="56" sid="null" wn="1" wnkey="normal%3:00:01::" text="Of the 23 subjects studied, 5 (3 affected and 2 normal) were heterozygous Ala/Val." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="7338" end="7344" sStart="null" offset="52" sid="null" wn="1" wnkey="normal%3:00:01::" text="Of these, 6 individuals (3 affected and 3 normal) were homozygous CC (exon 17), 15 (11 affected and 4 normal) were heterozygous TC (exon 17) and three were heterozygous AG (exon 23)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="17770" end="17776" sStart="null" offset="56" sid="null" wn="3" wnkey="normal%3:00:03::" text="Of the 23 subjects studied, 5 (3 affected and 2 normal) were heterozygous Ala/Val." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="7338" end="7344" sStart="null" offset="52" sid="null" wn="3" wnkey="normal%3:00:03::" text="Of these, 6 individuals (3 affected and 3 normal) were homozygous CC (exon 17), 15 (11 affected and 4 normal) were heterozygous TC (exon 17) and three were heterozygous AG (exon 23)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="14229" end="14235" sStart="null" offset="123" sid="r9.normal.j.0919" wn="3" wnkey="normal%3:00:03::" text="The seven families consist of five normal parents, five affected parents, seven affected patients, one normal sib and two affected members." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="17770" end="17776" sStart="null" offset="56" sid="null" wn="1" wnkey="normal%3:00:01::" text="Of the 23 subjects studied, 5 (3 affected and 2 normal) were heterozygous Ala/Val." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="7338" end="7344" sStart="null" offset="52" sid="null" wn="1" wnkey="normal%3:00:01::" text="Of these, 6 individuals (3 affected and 3 normal) were homozygous CC (exon 17), 15 (11 affected and 4 normal) were heterozygous TC (exon 17) and three were heterozygous AG (exon 23)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="7408" end="7414" sStart="null" offset="122" sid="r9.normal.j.0936" wn="1" wnkey="normal%3:00:01::" text="Of these, 6 individuals (3 affected and 3 normal) were homozygous CC (exon 17), 15 (11 affected and 4 normal) were heterozygous TC (exon 17) and three were heterozygous AG (exon 23)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="17871" end="17877" sStart="null" offset="66" sid="r9.normal.j.0736" wn="1" wnkey="normal%3:00:01::" text="1 (affected) homozygous Val/Val and 17 (13 affected and 4 normal) were homozygous Ala/Ala." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="7338" end="7344" sStart="null" offset="52" sid="r9.normal.j.0188" wn="1" wnkey="normal%3:00:01::" text="Of these, 6 individuals (3 affected and 3 normal) were homozygous CC (exon 17), 15 (11 affected and 4 normal) were heterozygous TC (exon 17) and three were heterozygous AG (exon 23)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="17770" end="17776" sStart="null" offset="56" sid="null" wn="1" wnkey="normal%3:00:01::" text="Of the 23 subjects studied, 5 (3 affected and 2 normal) were heterozygous Ala/Val." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="7338" end="7344" sStart="null" offset="52" sid="null" wn="1" wnkey="normal%3:00:01::" text="Of these, 6 individuals (3 affected and 3 normal) were homozygous CC (exon 17), 15 (11 affected and 4 normal) were heterozygous TC (exon 17) and three were heterozygous AG (exon 23)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2164-3-30.anc" start="8300" end="8304" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="AL357553) revealed that it is a large gene with a coding sequence of 3105 bp &lt;b&gt;long&lt;/b&gt;, having 23 exons spread over ~68." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2164-3-30.anc" start="6052" end="6056" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="AL357553) revealed that it is a large gene with a coding sequence of 3105 bp &lt;b&gt;long&lt;/b&gt;, having 23 exons spread over ~68." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2164-3-30.anc" start="10758" end="10762" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="The whole GPC5 gene is 2558 bp &lt;b&gt;long&lt;/b&gt; and encodes 572 amino acids." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2164-3-30.anc" start="8300" end="8304" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="AL357553) revealed that it is a large gene with a coding sequence of 3105 bp &lt;b&gt;long&lt;/b&gt;, having 23 exons spread over ~68." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2164-3-30.anc" start="8300" end="8304" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="AL357553) revealed that it is a large gene with a coding sequence of 3105 bp &lt;b&gt;long&lt;/b&gt;, having 23 exons spread over ~68." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2164-3-30.anc" start="8300" end="8304" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="AL357553) revealed that it is a large gene with a coding sequence of 3105 bp &lt;b&gt;long&lt;/b&gt;, having 23 exons spread over ~68." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2164-3-30.anc" start="8300" end="8304" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="AL357553) revealed that it is a large gene with a coding sequence of 3105 bp &lt;b&gt;long&lt;/b&gt;, having 23 exons spread over ~68." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2164-3-30.anc" start="8300" end="8304" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="AL357553) revealed that it is a large gene with a coding sequence of 3105 bp &lt;b&gt;long&lt;/b&gt;, having 23 exons spread over ~68." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2164-3-30.anc" start="8300" end="8304" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="AL357553) revealed that it is a large gene with a coding sequence of 3105 bp &lt;b&gt;long&lt;/b&gt;, having 23 exons spread over ~68." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="3853" end="3857" sStart="null" offset="344" sid="r10.high.j.0850" wn="1" wnkey="high%3:00:02::" text="GPC5 belongs to the cell surface heparan sulfate proteoglycan family and is expressed in limb, kidney, developing central nervous system and brain tissue [ 21 22 ] . In vertebrates 6 glypican family members belonging to the proteoglycan family have so far been characterized [ 23 ] . Although there is a high degree of conservation of polypeptide sequence among family members, they are localized to different chromosomes." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="3118" end="3126" sStart="null" offset="75" sid="r11.function.n.0248" wn="2" wnkey="function%1:07:00::" text="It is expressed in intestine, kidney, liver and brain [ 16 ] . The function of SLC15A1 is to absorb and transport small peptides [ 17 18 ] . The efficiency of absorption and transportation of L DOPA and its metabolite dopamine, which are neurotransmitter candidates, is increased by SLC15A1 [ 19 ] . Therefore, it is an important potential gene for future drug design, delivery, and targeting [ 20 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="9254" end="9262" sStart="null" offset="135" sid="r11.function.n.0822" wn="2" wnkey="function%1:07:00::" text="Tyrosine (Y167) and histidyl residues (H57, H111 and H121) are two of these amino acids playing important roles in the function of transporters [ 33 34 35 36 ] . In our mutation screening of families with Bipolar disorder we did not find variants at these positions." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="17604" end="17612" sStart="null" offset="85" sid="r8.family.n.0988" wn="2" wnkey="family%1:14:00::" text="While screening an additional three families, and reanalysis of our previous families we noted two variants in exon three: One was A155V (C&gt;T) and second was R223C (C&gt;T)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="3579" end="3585" sStart="null" offset="70" sid="r8.family.n.0600" wn="6" wnkey="family%1:14:03::" text="GPC5 belongs to the cell surface heparan sulfate proteoglycan family and is expressed in limb, kidney, developing central nervous system and brain tissue [ 21 22 ] . In vertebrates 6 glypican family members belonging to the proteoglycan family have so far been characterized [ 23 ] . Although there is a high degree of conservation of polypeptide sequence among family members, they are localized to different chromosomes." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="4768" end="4776" sStart="null" offset="679" sid="r8.family.n.0420" wn="6" wnkey="family%1:14:03::" text="Deletion of the 13q region is associated with human 13q syndrome, a developmental disorder [ 24 ] . Some of the proteoglycans play important functional roles in neurogenesis, axon guidance, synapse development [ 25 ] , and cellular growth and differentiation [ 26 27 23 ] . Mutations in GPC3 cause Simpson-Golabi-Behmel syndrome [ 28 29 ] , however, no mutations were detected in the GPC5 and GPC6 genes [ 30 ] . The glypican1 gene has been suggested to be a good candidate for brachydactyly type E [ 31 ] . Given that, GPC5 is highly expressed in brain and mutations in other genes of the glypican families are associated with developmental disorder; GPC5 could be a potential candidate gene for Bipolar disorder." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="17303" end="17311" sStart="null" offset="73" sid="r8.family.n.0591" wn="3" wnkey="family%1:14:04::" text="CYL &amp; Author 4, SD Participated in initial genotyping of the families." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="3725" end="3731" sStart="null" offset="216" sid="r8.family.n.0459" wn="3" wnkey="family%1:14:04::" text="GPC5 belongs to the cell surface heparan sulfate proteoglycan family and is expressed in limb, kidney, developing central nervous system and brain tissue [ 21 22 ] . In vertebrates 6 glypican family members belonging to the proteoglycan family have so far been characterized [ 23 ] . Although there is a high degree of conservation of polypeptide sequence among family members, they are localized to different chromosomes." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="13052" end="13061" sStart="null" offset="364" sid="r8.1.different.j.0052" wn="5" wnkey="different%5:00:01:other:00" text="3 confers susceptibility to Schizophrenia in the British population but not in the Japanese population [ 39 ] . Genetic heterogeneity is very common in hereditary deafness [ 40 ] ; also the prevalence of mutations in the connexin 26 gene is a major cause of non-syndromic autosomal recessive deafness that varies in different populations [ 41 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="13052" end="13061" sStart="null" offset="364" sid="r8.1.different.j.0052" wn="1" wnkey="different%3:00:00::" text="3 confers susceptibility to Schizophrenia in the British population but not in the Japanese population [ 39 ] . Genetic heterogeneity is very common in hereditary deafness [ 40 ] ; also the prevalence of mutations in the connexin 26 gene is a major cause of non-syndromic autosomal recessive deafness that varies in different populations [ 41 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="13052" end="13061" sStart="null" offset="364" sid="r8.1.different.j.0052" wn="1" wnkey="different%3:00:00::" text="3 confers susceptibility to Schizophrenia in the British population but not in the Japanese population [ 39 ] . Genetic heterogeneity is very common in hereditary deafness [ 40 ] ; also the prevalence of mutations in the connexin 26 gene is a major cause of non-syndromic autosomal recessive deafness that varies in different populations [ 41 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="13052" end="13061" sStart="null" offset="364" sid="r8.1.different.j.0052" wn="1" wnkey="different%3:00:00::" text="3 confers susceptibility to Schizophrenia in the British population but not in the Japanese population [ 39 ] . Genetic heterogeneity is very common in hereditary deafness [ 40 ] ; also the prevalence of mutations in the connexin 26 gene is a major cause of non-syndromic autosomal recessive deafness that varies in different populations [ 41 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="16757" end="16764" sStart="null" offset="80" sid="r10.control.n.0843" wn="4" wnkey="control%1:09:02::" text="The obtained sequences were compared with the corresponding control gene sequences using SEQUENCHER software (Gene codes corporation, Ann Arbor, MI, USA)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2164-3-30.anc" start="12854" end="12860" sStart="null" offset="166" sid="r10.common.j.0773" wn="4" wnkey="common%5:00:00:familiar:02" text="3 confers susceptibility to Schizophrenia in the British population but not in the Japanese population [ 39 ] . Genetic heterogeneity is very common in hereditary deafness [ 40 ] ; also the prevalence of mutations in the connexin 26 gene is a major cause of non-syndromic autosomal recessive deafness that varies in different populations [ 41 ] ." />
  </sentences>
</list>